La Cava A - Search Results

1

H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse.

La Cava A, Balasa B, Good A, van Gunst K, Jung N, Sarvetnick N. La Cava A, et al. J Immunol. 2001 Jul 15;167(2):1066-71. doi: 10.4049/jimmunol.167.2.1066. J Immunol. 2001. PMID: 11441117

2

Ontogeny of synonymous T cell populations with specificity for a self MHC epitope mimicked by a bacterial homologoue: an antigen-specific T cell analysis in a non-transgenic system.

Bonnin D, Prakken B, Samodal R, La Cava A, Carson DA, Albani S. Bonnin D, et al. Among authors: la cava a. Eur J Immunol. 1999 Dec;29(12):3826-36. doi: 10.1002/(SICI)1521-4141(199912)29:12<3826::AID-IMMU3826>3.0.CO;2-S. Eur J Immunol. 1999. PMID: 10601990 Free article.

3

Cell-mediated DNA transport between distant inflammatory sites following intradermal DNA immunization in the presence of adjuvant.

La Cava A, Billetta R, Gaietta G, Bonnin DB, Baird SM, Albani S. La Cava A, et al. J Immunol. 2000 Feb 1;164(3):1340-5. doi: 10.4049/jimmunol.164.3.1340. J Immunol. 2000. PMID: 10640748

4

Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.

Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvetnick N. Horwitz MS, et al. Among authors: la cava a. Nat Med. 2000 Jun;6(6):693-7. doi: 10.1038/76277. Nat Med. 2000. PMID: 10835688

5

A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.

Balasa B, La Cava A, Van Gunst K, Mocnik L, Balakrishna D, Nguyen N, Tucker L, Sarvetnick N. Balasa B, et al. Among authors: la cava a. J Immunol. 2000 Dec 15;165(12):7330-7. doi: 10.4049/jimmunol.165.12.7330. J Immunol. 2000. PMID: 11120869

6

The role of cytokines in autoimmunity.

La Cava A, Sarvetnick N. La Cava A, et al. Curr Dir Autoimmun. 1999;1:56-71. doi: 10.1159/000060495. Curr Dir Autoimmun. 1999. PMID: 11791448 Review. No abstract available.

7

Leptin accelerates autoimmune diabetes in female NOD mice.

Matarese G, Sanna V, Lechler RI, Sarvetnick N, Fontana S, Zappacosta S, La Cava A. Matarese G, et al. Among authors: la cava a. Diabetes. 2002 May;51(5):1356-61. doi: 10.2337/diabetes.51.5.1356. Diabetes. 2002. PMID: 11978630

8

Autoreactive T cells mediate NK cell degeneration in autoimmune disease.

Liu R, Van Kaer L, La Cava A, Price M, Campagnolo DI, Collins M, Young DA, Vollmer TL, Shi FD. Liu R, et al. Among authors: la cava a. J Immunol. 2006 May 1;176(9):5247-54. doi: 10.4049/jimmunol.176.9.5247. J Immunol. 2006. PMID: 16621990

9

Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA.

La Cava A, Ebling FM, Hahn BH. La Cava A, et al. J Immunol. 2004 Sep 1;173(5):3542-8. doi: 10.4049/jimmunol.173.5.3542. J Immunol. 2004. PMID: 15322219

10

Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors.

Hahn BH, Singh RP, La Cava A, Ebling FM. Hahn BH, et al. Among authors: la cava a. J Immunol. 2005 Dec 1;175(11):7728-37. doi: 10.4049/jimmunol.175.11.7728. J Immunol. 2005. PMID: 16301683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters